The gut microbiome as novel cardio-metabolic target: the time has come!
Authors:
Open Access
- 11 November 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 35 (14) , 883-887
Abstract
Recent studies reveal a potential contribution of intestinal microbes in the expression of certain human cardio-metabolic diseases. The mechanisms through which intestinal microbiota and/or their metabolic products alter systemic homoeostasis and cardio-metabolic disease risks are just beginning to be dissected. Intervention studies in humans aiming to either selectively alter the composition of the intestinal microbiota or to pharmacologically manipulate the microbiota to influence production of their metabolites are crucial next steps. The intestinal microbiome represents a new potential therapeutic target for the treatment of cardio-metabolic diseases.Keywords
This publication has 58 references indexed in Scilit:
- Short-Chain Fatty Acids Activate GPR41 and GPR43 on Intestinal Epithelial Cells to Promote Inflammatory Responses in MiceGastroenterology, 2013
- A metagenome-wide association study of gut microbiota in type 2 diabetesNature, 2012
- Red Meat Consumption and MortalityArchives of internal medicine (1960), 2012
- Linking Long-Term Dietary Patterns with Gut Microbial EnterotypesScience, 2011
- Detection of Periodontal Bacteria in Atheromatous Plaque by Nested Polymerase Chain ReactionJournal of Periodontology, 2011
- Role of flagellin in Crohnʼs disease: Emblematic of the progress and enigmas in understanding inflammatory bowel diseaseInflammatory Bowel Diseases, 2009
- Mechanisms underlying the resistance to diet-induced obesity in germ-free miceProceedings of the National Academy of Sciences, 2007
- Differences in Fecal Microbiota in Different European Study Populations in Relation to Age, Gender, and Country: a Cross-Sectional StudyApplied and Environmental Microbiology, 2006
- The gut microbiota as an environmental factor that regulates fat storageProceedings of the National Academy of Sciences, 2004
- Parenteral Nutrition Facilitates Activation of Coagulation but Not of Fibrinolysis during Human EndotoxemiaThe Journal of Infectious Diseases, 1998